Cristian Navarrete-Dechent1, Miguel Cordova2, Konstantinos Liopyris2, Saud Aleissa2, Milind Rajadhyaksha2, Gil'ad Cohen3, Ashfaq A Marghoob2, Anthony M Rossi2, Christopher A Barker4. 1. Department of Dermatology, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. 2. Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. 3. Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. 4. Brachytherapy Service, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: barkerc@mskcc.org.
Abstract
BACKGROUND: Radiation therapy (RT) is a treatment option for select skin cancers. The histologic effects of RT on normal skin or skin cancers are not well characterized. Dermoscopy, high-frequency ultrasonography (HFUS), and reflectance confocal microscopy (RCM) are noninvasive imaging modalities that may help characterize RT response. OBJECTIVES: To describe changes in the tumor and surrounding skin of patients with basal cell carcinoma (BCC) treated with RT. METHODS: The study was conducted between 2014 and 2018. Patients with biopsy-proven BCCs were treated with 42 Gy in 6 fractions using a commercially available brachytherapy device. Dermoscopy, HFUS, and RCM were performed before treatment and at 6 weeks, 3 months, and 12 months after RT. RESULTS: A total of 137 imaging assessments (RCM + dermoscopy + HFUS) were performed in 12 patients. BCC-specific features were present in 81.8%, 91%, and 17% of patients imaged with dermoscopy, RCM, and HFUS at baseline, respectively, before treatment. After treatment, the resolution of these features was noted in 33.4%, 91.7%, and 100% of patients imaged with the respective modalities. No recurrences were seen after a mean of 31.7 months of follow-up. LIMITATIONS: Small sample size and no histopathologic correlation. CONCLUSION: Dermoscopy and HFUS were not as reliable as RCM at characterizing BCC RT response.
BACKGROUND: Radiation therapy (RT) is a treatment option for select skin cancers. The histologic effects of RT on normal skin or skin cancers are not well characterized. Dermoscopy, high-frequency ultrasonography (HFUS), and reflectance confocal microscopy (RCM) are noninvasive imaging modalities that may help characterize RT response. OBJECTIVES: To describe changes in the tumor and surrounding skin of patients with basal cell carcinoma (BCC) treated with RT. METHODS: The study was conducted between 2014 and 2018. Patients with biopsy-proven BCCs were treated with 42 Gy in 6 fractions using a commercially available brachytherapy device. Dermoscopy, HFUS, and RCM were performed before treatment and at 6 weeks, 3 months, and 12 months after RT. RESULTS: A total of 137 imaging assessments (RCM + dermoscopy + HFUS) were performed in 12 patients. BCC-specific features were present in 81.8%, 91%, and 17% of patients imaged with dermoscopy, RCM, and HFUS at baseline, respectively, before treatment. After treatment, the resolution of these features was noted in 33.4%, 91.7%, and 100% of patients imaged with the respective modalities. No recurrences were seen after a mean of 31.7 months of follow-up. LIMITATIONS: Small sample size and no histopathologic correlation. CONCLUSION: Dermoscopy and HFUS were not as reliable as RCM at characterizing BCC RT response.
Authors: Cristian Navarrete-Dechent; Antonio P DeRosa; Caterina Longo; Konstantinos Liopyris; Margaret Oliviero; Harold Rabinovitz; Ashfaq A Marghoob; Allan C Halpern; Giovanni Pellacani; Alon Scope; Manu Jain Journal: J Am Acad Dermatol Date: 2018-12-08 Impact factor: 11.527
Authors: Konstantinos Liopyris; Cristian Navarrete-Dechent; Stephen W Dusza; Ashfaq A Marghoob; Liang Deng; Barbara B Wilson; Michael A Marchetti Journal: Australas J Dermatol Date: 2018-11-18 Impact factor: 2.875
Authors: S Vano-Galvan; E Fernandez-Lizarbe; M Truchuelo; B Diaz-Ley; E Grillo; V Sanchez; L Ríos-Buceta; J Paoli; S Sancho; A Montero; R Hernanz; A Ramos; P Jaen; S Gonzalez Journal: J Eur Acad Dermatol Venereol Date: 2012-08-11 Impact factor: 6.166
Authors: John Y S Kim; Jeffrey H Kozlow; Bharat Mittal; Jeffrey Moyer; Thomas Olencki; Phillip Rodgers Journal: J Am Acad Dermatol Date: 2018-01-10 Impact factor: 11.527
Authors: Peter R Jermain; Tyler W Iorizzo; Mary Maloney; Bassel Mahmoud; Anna N Yaroslavsky Journal: Cancers (Basel) Date: 2022-08-22 Impact factor: 6.575